Global Trac Solutions, Inc. CEO, David Flores, sits down once again with Founder & CEO of The Third Wave, Paul F. Austin. The two begin their conversation with accessibility & affordability, concepts that are commonly overlooked in psychedelic medicine. They then dive into what it would take to create an infrastructure that ensures a very important segment of our society is able to gain access to the powerful, and profound benefits available through the use of psychedelic medicine.
Similar Posts
Australia’s First Psychedelic Research Institute Opens with $40 Million Investment
Psychae Institute will collaborate with other clinical research organizations to develop novel psychedelic medicines and accompanying psychotherapeutic treatment models.
Lamar Odom Documentary About His Recovery Through Psychedelics Makes Its Debut
Former NBA star Lamar Odom details his recovery from substance abuse with the aid of psychedelic medicine in a new documentary.
Why Mindset Pharma’s Deal with Big Pharma Is a Big Deal for Psychedelics
The partnership with global pharmaceutical company Otsuka positions the psychedelic medicine company as a leader in the industry.
Psychedelic Researchers Doubt Microdosing in New York Times
After a disappointing microdosing study, Dr. Michiel van Elk says the trend is “just not that interesting.”
Why Diversity, Equity and Inclusion Are Vital to the Psychedelic Industry
Steven Huang, a consultant for leading psychedelic medicine company Numinus, explains why the industry should “harness the power of diversity.”
The Spiritual Reason Michael Pollan Explores Mescaline in New Book ‘This Is Your Mind on Plants’
The author’s latest deep dive into plants’ effect on consciousness also investigates caffeine and opium.